LNAI
Lunai Bioworks Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$11.33M
P/E Ratio
—
EPS
$-61.52
Beta
0.36
52W High
$31.76
52W Low
$1.21
50-Day MA
$2.60
200-Day MA
$6.93
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Lunai Bioworks Inc.
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. The company is headquartered in Los Angeles, California.
Fundamentals
| Revenue (TTM) | 20,940 |
| Gross Profit (TTM) | 20,940 |
| EBITDA | $-9.77M |
| Operating Margin | -6815.00% |
| Return on Equity | -325.50% |
| Return on Assets | -9.65% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $-2.14 |
| Price-to-Book | 0.48 |
| Price-to-Sales (TTM) | 541.24 |
| EV/Revenue | 462.3 |
| EV/EBITDA | -7.37 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $4.53M |
| Float | $3.35M |
| % Insiders | 31.30% |
| % Institutions | 2.76% |
Historical Volatility
HV 10-Day
108.58%
HV 20-Day
165.10%
HV 30-Day
138.78%
HV 60-Day
169.44%
HV Rank
—
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 6/13/2026